| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transcranial Direct Current Stimulation | 23 | 2019 | 107 | 6.56 | Why? |
| Motor Cortex | 10 | 2019 | 71 | 4.07 | Why? |
| Neuronal Plasticity | 9 | 2019 | 98 | 2.46 | Why? |
| Evoked Potentials, Motor | 8 | 2019 | 54 | 2.44 | Why? |
| Cowpox virus | 6 | 2018 | 19 | 2.44 | Why? |
| Orthopoxvirus | 5 | 2018 | 29 | 2.35 | Why? |
| High-Throughput Nucleotide Sequencing | 15 | 2021 | 3633 | 1.80 | Why? |
| Smallpox Vaccine | 4 | 2018 | 46 | 1.72 | Why? |
| Transcranial Magnetic Stimulation | 10 | 2019 | 160 | 1.68 | Why? |
| Poxviridae Infections | 3 | 2017 | 31 | 1.33 | Why? |
| Virion | 4 | 2021 | 1444 | 1.33 | Why? |
| Cowpox | 3 | 2017 | 14 | 1.09 | Why? |
| Metagenomics | 4 | 2018 | 823 | 1.05 | Why? |
| Smallpox | 3 | 2017 | 96 | 0.94 | Why? |
| Poxviridae | 3 | 2017 | 23 | 0.93 | Why? |
| Sequence Analysis, DNA | 8 | 2019 | 2830 | 0.82 | Why? |
| Ubiquitination | 2 | 2018 | 343 | 0.79 | Why? |
| Nervous System Physiological Phenomena | 1 | 2018 | 14 | 0.76 | Why? |
| Laboratory Proficiency Testing | 1 | 2019 | 85 | 0.75 | Why? |
| Viruses | 6 | 2019 | 2238 | 0.73 | Why? |
| Vaccinia virus | 2 | 2017 | 346 | 0.72 | Why? |
| Adrenergic Uptake Inhibitors | 1 | 2017 | 11 | 0.72 | Why? |
| Functional Laterality | 1 | 2017 | 57 | 0.70 | Why? |
| Ticks | 4 | 2019 | 107 | 0.70 | Why? |
| Hemorrhagic Fevers, Viral | 1 | 2017 | 26 | 0.70 | Why? |
| Viral Core Proteins | 1 | 2018 | 134 | 0.68 | Why? |
| Horse Diseases | 1 | 2017 | 101 | 0.64 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2018 | 249 | 0.63 | Why? |
| Frontal Lobe | 1 | 2017 | 191 | 0.62 | Why? |
| Executive Function | 1 | 2017 | 173 | 0.60 | Why? |
| Morpholines | 1 | 2017 | 351 | 0.59 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.57 | Why? |
| Varenicline | 1 | 2014 | 28 | 0.57 | Why? |
| Prefrontal Cortex | 5 | 2019 | 151 | 0.56 | Why? |
| Yellow fever virus | 3 | 2018 | 205 | 0.56 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.55 | Why? |
| Cognition | 4 | 2018 | 1394 | 0.55 | Why? |
| Nicotinic Agonists | 1 | 2014 | 56 | 0.54 | Why? |
| Phlebovirus | 3 | 2019 | 106 | 0.50 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.50 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.49 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.48 | Why? |
| Molecular Diagnostic Techniques | 3 | 2021 | 4239 | 0.47 | Why? |
| Flavivirus | 3 | 2018 | 182 | 0.45 | Why? |
| Proteome | 3 | 2019 | 1812 | 0.44 | Why? |
| Memory, Short-Term | 4 | 2019 | 137 | 0.42 | Why? |
| Learning | 2 | 2018 | 1181 | 0.41 | Why? |
| Receptors, Dopamine D1 | 1 | 2009 | 9 | 0.40 | Why? |
| Nucleic Acid Amplification Techniques | 3 | 2019 | 3388 | 0.38 | Why? |
| Proteomics | 4 | 2021 | 2481 | 0.38 | Why? |
| Genome, Viral | 10 | 2019 | 13157 | 0.37 | Why? |
| Viral Proteins | 6 | 2021 | 7370 | 0.37 | Why? |
| Brain | 4 | 2020 | 5133 | 0.37 | Why? |
| Rhabdoviridae | 2 | 2018 | 10 | 0.36 | Why? |
| Computational Biology | 3 | 2019 | 4514 | 0.34 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.34 | Why? |
| History, 19th Century | 3 | 2018 | 384 | 0.34 | Why? |
| Deep Brain Stimulation | 1 | 2010 | 203 | 0.34 | Why? |
| Analysis of Variance | 4 | 2017 | 950 | 0.33 | Why? |
| DNA, Viral | 7 | 2018 | 2521 | 0.33 | Why? |
| Psychomotor Performance | 2 | 2018 | 110 | 0.32 | Why? |
| Hemorrhagic Fever Virus, Crimean-Congo | 2 | 2017 | 133 | 0.32 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.32 | Why? |
| Virus Diseases | 5 | 2020 | 3779 | 0.31 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.31 | Why? |
| West Nile virus | 2 | 2017 | 206 | 0.30 | Why? |
| Single-Blind Method | 3 | 2018 | 1283 | 0.30 | Why? |
| Culicidae | 2 | 2017 | 239 | 0.29 | Why? |
| Cytomegalovirus | 3 | 2010 | 600 | 0.28 | Why? |
| Polymerase Chain Reaction | 9 | 2020 | 6740 | 0.28 | Why? |
| Cerebral Cortex | 2 | 2018 | 276 | 0.27 | Why? |
| Animals | 28 | 2021 | 78931 | 0.27 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.27 | Why? |
| Anxiety Disorders | 1 | 2017 | 2290 | 0.26 | Why? |
| Software | 4 | 2019 | 2501 | 0.26 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 11367 | 0.26 | Why? |
| Herpesvirus 6, Human | 1 | 2005 | 162 | 0.25 | Why? |
| History, 20th Century | 3 | 2018 | 1282 | 0.25 | Why? |
| Seroepidemiologic Studies | 2 | 2020 | 10017 | 0.24 | Why? |
| Phylogeny | 12 | 2019 | 13341 | 0.24 | Why? |
| Substance-Related Disorders | 1 | 2017 | 2038 | 0.24 | Why? |
| Rats, Wistar | 3 | 2019 | 621 | 0.23 | Why? |
| Variola virus | 2 | 2018 | 33 | 0.23 | Why? |
| Genes, Viral | 2 | 2018 | 1428 | 0.22 | Why? |
| RNA, Viral | 8 | 2021 | 32276 | 0.22 | Why? |
| Electron Microscope Tomography | 1 | 2021 | 167 | 0.21 | Why? |
| Humans | 71 | 2021 | 930598 | 0.21 | Why? |
| Virology | 3 | 2020 | 489 | 0.21 | Why? |
| History, 18th Century | 2 | 2018 | 192 | 0.21 | Why? |
| Communication Disorders | 1 | 2020 | 49 | 0.21 | Why? |
| Amantadine | 1 | 2021 | 79 | 0.20 | Why? |
| Flavivirus Infections | 2 | 2018 | 81 | 0.20 | Why? |
| Wernicke Area | 1 | 2019 | 1 | 0.20 | Why? |
| GAP-43 Protein | 1 | 2019 | 5 | 0.20 | Why? |
| Memory, Long-Term | 1 | 2019 | 4 | 0.20 | Why? |
| Verbal Learning | 1 | 2019 | 15 | 0.20 | Why? |
| Vocabulary | 1 | 2019 | 13 | 0.20 | Why? |
| Cercopithecidae | 1 | 2018 | 7 | 0.20 | Why? |
| Receptors, AMPA | 1 | 2019 | 17 | 0.20 | Why? |
| Catechol O-Methyltransferase | 1 | 2019 | 25 | 0.20 | Why? |
| Genetic Privacy | 1 | 2018 | 10 | 0.19 | Why? |
| Neural Inhibition | 1 | 2018 | 19 | 0.19 | Why? |
| Arvicolinae | 1 | 2018 | 49 | 0.19 | Why? |
| Toluene | 1 | 2018 | 21 | 0.19 | Why? |
| Archives | 1 | 2018 | 34 | 0.19 | Why? |
| Polyubiquitin | 1 | 2018 | 14 | 0.19 | Why? |
| Acinonyx | 1 | 2017 | 8 | 0.18 | Why? |
| Mental Recall | 1 | 2019 | 77 | 0.18 | Why? |
| Time Perception | 1 | 2018 | 13 | 0.18 | Why? |
| Yellow Fever | 2 | 2018 | 231 | 0.18 | Why? |
| Criminals | 1 | 2018 | 56 | 0.18 | Why? |
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 37 | 0.18 | Why? |
| Dimethyl Sulfoxide | 1 | 2018 | 35 | 0.18 | Why? |
| Immunomodulation | 2 | 2017 | 1472 | 0.18 | Why? |
| Hantavirus | 1 | 2018 | 63 | 0.18 | Why? |
| Amphetamine-Related Disorders | 1 | 2018 | 31 | 0.18 | Why? |
| Sciuridae | 1 | 2017 | 22 | 0.18 | Why? |
| Junin virus | 1 | 2017 | 28 | 0.18 | Why? |
| West Nile Fever | 2 | 2017 | 166 | 0.18 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.18 | Why? |
| Rift Valley fever virus | 1 | 2017 | 48 | 0.17 | Why? |
| Judgment | 1 | 2018 | 98 | 0.17 | Why? |
| Cote d'Ivoire | 1 | 2017 | 115 | 0.17 | Why? |
| Corpus Striatum | 1 | 2018 | 49 | 0.17 | Why? |
| Tourette Syndrome | 1 | 2018 | 41 | 0.17 | Why? |
| Aggression | 1 | 2018 | 126 | 0.17 | Why? |
| Craving | 1 | 2018 | 43 | 0.17 | Why? |
| Mass Spectrometry | 2 | 2020 | 1165 | 0.17 | Why? |
| DNA Replication | 1 | 2018 | 121 | 0.17 | Why? |
| Olfactory Mucosa | 1 | 2020 | 372 | 0.17 | Why? |
| Founder Effect | 1 | 2017 | 92 | 0.17 | Why? |
| Bacteria | 2 | 2019 | 1897 | 0.17 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.17 | Why? |
| Cross-Over Studies | 2 | 2018 | 867 | 0.17 | Why? |
| Tyrosine | 1 | 2017 | 66 | 0.17 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.17 | Why? |
| Nerve Net | 1 | 2018 | 118 | 0.17 | Why? |
| Methamphetamine | 1 | 2018 | 82 | 0.16 | Why? |
| Plastics | 1 | 2021 | 463 | 0.16 | Why? |
| Psychological Tests | 1 | 2017 | 152 | 0.16 | Why? |
| Culex | 1 | 2017 | 66 | 0.16 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2017 | 239 | 0.16 | Why? |
| Cell Culture Techniques | 2 | 2018 | 704 | 0.16 | Why? |
| Skin Ulcer | 1 | 2017 | 98 | 0.16 | Why? |
| Animal Diseases | 1 | 2018 | 182 | 0.16 | Why? |
| Horses | 1 | 2017 | 474 | 0.15 | Why? |
| Democratic Republic of the Congo | 1 | 2017 | 500 | 0.15 | Why? |
| Ubiquitin | 1 | 2018 | 243 | 0.15 | Why? |
| Rats | 3 | 2018 | 2764 | 0.15 | Why? |
| Genetic Fitness | 1 | 2017 | 339 | 0.15 | Why? |
| Behavior | 1 | 2018 | 252 | 0.15 | Why? |
| Turkey | 7 | 2019 | 3937 | 0.15 | Why? |
| Neurosciences | 1 | 2017 | 148 | 0.14 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 13720 | 0.14 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.14 | Why? |
| Adult | 23 | 2021 | 244371 | 0.14 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.14 | Why? |
| Biophysics | 1 | 2014 | 30 | 0.14 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.14 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.14 | Why? |
| Upper Extremity | 1 | 2017 | 193 | 0.14 | Why? |
| Young Adult | 12 | 2019 | 93724 | 0.14 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.14 | Why? |
| Mental Disorders | 1 | 2017 | 6742 | 0.14 | Why? |
| SARS Virus | 5 | 2020 | 13021 | 0.13 | Why? |
| Electrodes | 2 | 2017 | 203 | 0.13 | Why? |
| Virus Cultivation | 1 | 2017 | 579 | 0.13 | Why? |
| Autistic Disorder | 1 | 2018 | 253 | 0.13 | Why? |
| Reaction Time | 3 | 2018 | 96 | 0.13 | Why? |
| Aedes | 1 | 2017 | 380 | 0.13 | Why? |
| Amino Acid Sequence | 4 | 2021 | 6049 | 0.13 | Why? |
| Stroke Rehabilitation | 1 | 2017 | 299 | 0.13 | Why? |
| Pyridones | 1 | 2019 | 738 | 0.12 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.12 | Why? |
| Peptides | 3 | 2021 | 2513 | 0.12 | Why? |
| Host Specificity | 1 | 2017 | 926 | 0.12 | Why? |
| Hand | 1 | 2017 | 449 | 0.12 | Why? |
| Violence | 1 | 2018 | 534 | 0.12 | Why? |
| Cell Line | 5 | 2020 | 12040 | 0.12 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.12 | Why? |
| Male | 27 | 2020 | 367725 | 0.12 | Why? |
| Intersectoral Collaboration | 1 | 2019 | 1065 | 0.12 | Why? |
| Neurons | 1 | 2018 | 864 | 0.12 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.12 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 441 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Laboratories | 3 | 2021 | 2858 | 0.11 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.10 | Why? |
| Biological Specimen Banks | 1 | 2018 | 1142 | 0.10 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Sulpiride | 1 | 2009 | 11 | 0.10 | Why? |
| Dopamine Agents | 1 | 2009 | 20 | 0.10 | Why? |
| Workflow | 1 | 2019 | 2373 | 0.10 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.10 | Why? |
| Electric Stimulation | 1 | 2009 | 84 | 0.10 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.10 | Why? |
| Germany | 6 | 2021 | 9196 | 0.09 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.09 | Why? |
| Cognitive Dysfunction | 1 | 2020 | 1389 | 0.09 | Why? |
| Female | 21 | 2020 | 380317 | 0.09 | Why? |
| Bipolar Disorder | 1 | 2017 | 744 | 0.09 | Why? |
| Betaherpesvirinae | 1 | 2007 | 1 | 0.09 | Why? |
| Levodopa | 1 | 2009 | 87 | 0.09 | Why? |
| Rhadinovirus | 1 | 2007 | 7 | 0.09 | Why? |
| Microscopy, Electron, Transmission | 1 | 2011 | 605 | 0.09 | Why? |
| Gammaherpesvirinae | 1 | 2007 | 10 | 0.09 | Why? |
| Electric Stimulation Therapy | 1 | 2010 | 151 | 0.09 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.09 | Why? |
| Neurosurgical Procedures | 1 | 2019 | 1738 | 0.08 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Education, Nursing | 1 | 1992 | 425 | 0.08 | Why? |
| TATA-Box Binding Protein | 1 | 2005 | 3 | 0.08 | Why? |
| Peptidylprolyl Isomerase | 1 | 2005 | 10 | 0.08 | Why? |
| Eukaryotic Cells | 1 | 2005 | 6 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.08 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.08 | Why? |
| Europe | 2 | 2019 | 12702 | 0.07 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.07 | Why? |
| Health Resources | 1 | 2018 | 2592 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 1 | 2014 | 3776 | 0.07 | Why? |
| Virus Internalization | 2 | 2020 | 7921 | 0.07 | Why? |
| Phosphorylation | 2 | 2018 | 1060 | 0.07 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.07 | Why? |
| Health Priorities | 1 | 1992 | 959 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.07 | Why? |
| Species Specificity | 2 | 2019 | 1356 | 0.07 | Why? |
| Picornaviridae Infections | 1 | 2009 | 544 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.06 | Why? |
| Tandem Mass Spectrometry | 2 | 2021 | 1031 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Zoonoses | 1 | 2017 | 3034 | 0.06 | Why? |
| Rhinovirus | 1 | 2009 | 979 | 0.06 | Why? |
| Fluorescent Antibody Technique | 2 | 2017 | 835 | 0.06 | Why? |
| Neuropsychological Tests | 2 | 2019 | 954 | 0.06 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2007 | 12361 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.06 | Why? |
| Communication Aids for Disabled | 1 | 2020 | 12 | 0.06 | Why? |
| Health Education | 1 | 1992 | 1539 | 0.05 | Why? |
| Air Pollutants | 1 | 2018 | 3110 | 0.05 | Why? |
| Reference Standards | 1 | 2005 | 1163 | 0.05 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.05 | Why? |
| Ammonium Chloride | 1 | 2020 | 79 | 0.05 | Why? |
| Gabexate | 1 | 2020 | 88 | 0.05 | Why? |
| Francisella | 1 | 2019 | 4 | 0.05 | Why? |
| Theileria | 1 | 2019 | 8 | 0.05 | Why? |
| Coxiella | 1 | 2019 | 6 | 0.05 | Why? |
| Mental Status and Dementia Tests | 1 | 2020 | 208 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.05 | Why? |
| Maze Learning | 1 | 2019 | 35 | 0.05 | Why? |
| Babesia | 1 | 2019 | 15 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Arthropods | 1 | 2019 | 27 | 0.05 | Why? |
| Borrelia | 1 | 2019 | 39 | 0.05 | Why? |
| Leucine | 1 | 2020 | 121 | 0.05 | Why? |
| Management Service Organizations | 1 | 2018 | 28 | 0.05 | Why? |
| Toxicity Tests, Acute | 1 | 2018 | 22 | 0.05 | Why? |
| Long-Term Potentiation | 1 | 2018 | 19 | 0.05 | Why? |
| Arthropod Vectors | 1 | 2019 | 35 | 0.05 | Why? |
| DNA Barcoding, Taxonomic | 1 | 2018 | 39 | 0.05 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.05 | Why? |
| Rhabdoviridae Infections | 1 | 2018 | 23 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Rickettsia | 1 | 2019 | 101 | 0.05 | Why? |
| Dopamine | 1 | 2019 | 123 | 0.05 | Why? |
| Acetylation | 1 | 2018 | 124 | 0.04 | Why? |
| Task Performance and Analysis | 1 | 2018 | 68 | 0.04 | Why? |
| Imines | 1 | 2017 | 15 | 0.04 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.04 | Why? |
| Peptide Library | 1 | 2021 | 564 | 0.04 | Why? |
| Synapsins | 1 | 2017 | 9 | 0.04 | Why? |
| Esters | 1 | 2020 | 300 | 0.04 | Why? |
| CREB-Binding Protein | 1 | 2017 | 12 | 0.04 | Why? |
| Rest | 1 | 2018 | 188 | 0.04 | Why? |
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 27 | 0.04 | Why? |
| Animals, Zoo | 1 | 2017 | 106 | 0.04 | Why? |
| Individuality | 1 | 2019 | 142 | 0.04 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 159 | 0.04 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2018 | 368 | 0.04 | Why? |
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 50 | 0.04 | Why? |
| Homicide | 1 | 2018 | 115 | 0.04 | Why? |
| Berlin | 1 | 2017 | 283 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Keratinocytes | 1 | 2017 | 119 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2021 | 23402 | 0.04 | Why? |
| Central Nervous System Stimulants | 1 | 2018 | 111 | 0.04 | Why? |
| Cytoskeletal Proteins | 1 | 2017 | 63 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Bunyaviridae Infections | 1 | 2018 | 107 | 0.04 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.04 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.04 | Why? |
| Base Sequence | 2 | 2017 | 3581 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 133 | 0.04 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Geography, Medical | 1 | 2018 | 537 | 0.04 | Why? |
| Comprehension | 1 | 2019 | 259 | 0.04 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.04 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.04 | Why? |
| Central Nervous System | 1 | 2020 | 701 | 0.04 | Why? |
| Databases, Protein | 1 | 2019 | 523 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.03 | Why? |
| Germany, East | 1 | 1992 | 2 | 0.03 | Why? |
| Nitriles | 1 | 2019 | 1053 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.03 | Why? |
| Language | 1 | 2019 | 655 | 0.03 | Why? |
| Molecular Sequence Data | 2 | 2010 | 3198 | 0.03 | Why? |
| Treatment Outcome | 5 | 2018 | 51732 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.03 | Why? |
| Contact Tracing | 1 | 2013 | 8448 | 0.03 | Why? |
| Child | 3 | 2017 | 70012 | 0.03 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 116 | 0.03 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.03 | Why? |
| Chiroptera | 1 | 2007 | 3530 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 393 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Pyridines | 1 | 2017 | 680 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Anti-Infective Agents, Local | 1 | 2017 | 520 | 0.03 | Why? |
| Electroencephalography | 1 | 2018 | 1242 | 0.03 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.03 | Why? |
| Safety | 1 | 2018 | 1583 | 0.03 | Why? |
| Qatar | 1 | 2013 | 784 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Denmark | 1 | 2017 | 2654 | 0.03 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 9706 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Prisons | 1 | 2018 | 980 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.02 | Why? |
| Occupational Exposure | 2 | 2018 | 4742 | 0.02 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.02 | Why? |
| Disease Notification | 1 | 2013 | 639 | 0.02 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Fatigue | 1 | 2017 | 2479 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.02 | Why? |
| Skin | 1 | 2017 | 2096 | 0.02 | Why? |
| Carboxypeptidases | 1 | 2005 | 148 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Data Interpretation, Statistical | 1 | 2009 | 657 | 0.02 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Open Reading Frames | 1 | 2010 | 1898 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2013 | 1529 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.01 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Regression Analysis | 1 | 2009 | 2484 | 0.01 | Why? |
| Viral Nonstructural Proteins | 1 | 2017 | 4810 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.01 | Why? |
| Neutralization Tests | 1 | 2013 | 6698 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Curriculum | 1 | 1992 | 3083 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Cats | 1 | 2005 | 1890 | 0.01 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 8843 | 0.01 | Why? |
| Acute Disease | 1 | 2009 | 6029 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Swine | 1 | 2005 | 3352 | 0.01 | Why? |
| Travel | 1 | 2013 | 7220 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.01 | Why? |
| Mutation | 1 | 2010 | 12376 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Risk Assessment | 1 | 2013 | 25439 | 0.01 | Why? |
| Infant | 1 | 2009 | 30274 | 0.00 | Why? |
| Surveys and Questionnaires | 1 | 2013 | 43792 | 0.00 | Why? |
| Child, Preschool | 1 | 2009 | 36283 | 0.00 | Why? |
| Health Personnel | 1 | 2013 | 29646 | 0.00 | Why? |